Today: 7 February 2026
Subscribe
Browse Category

NYSE:BTI News 12 December 2025 - 23 January 2026

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

NEW YORK, Jan 15, 2026, 15:42 EST — Regular session. Philip Morris International Inc shares climbed Thursday after the company revealed it has poured over $20 billion into U.S.-related investments since 2022, with more spending on the horizon. The stock added $1.40, or roughly 0.8%, reaching $172.48 in afternoon trading. (Business Wire) The update arrives as investors seek signs that the tobacco giant’s growth is tilting toward “smoke-free” offerings — nicotine pouches and heated tobacco — over conventional cigarettes. In the U.S., regulators still hold the keys, making timing just as crucial as capturing market share. Philip Morris revealed that
15 January 2026
······
BAT stock in focus: British American Tobacco buyback update hits ahead of February results

BAT stock in focus: British American Tobacco buyback update hits ahead of February results

London, Jan 15, 2026, 07:37 GMT — Premarket British American Tobacco said it bought back 118,229 shares on Jan. 14 at prices between 4,160p and 4,245p, paying a volume-weighted average price (VWAP, a volume-weighted trading price) of 4,197.4176p. It said it would cancel the shares, taking the number of voting shares in issue to 2,178,299,552, excluding treasury stock. (Investegate) The buyback matters now because it is one of the few company-specific signals ahead of results season. BAT extended its share repurchase programme by up to 1.3 billion pounds for 2026 and put UBS in charge of buying shares independently during
15 January 2026
······
British American Tobacco stock edges up after fresh buyback update as Feb results loom

British American Tobacco stock edges up after fresh buyback update as Feb results loom

LONDON, Jan 8, 2026, 09:51 GMT — Regular session British American Tobacco (BATS.L) shares rose 0.3% to 3,979 pence by 0933 GMT, trimming a two-day slide in the London-listed tobacco group. In the United States, its ADR (BTI) was down about 1.4% in early premarket trading. SharePrices The move followed a new buyback disclosure that kept attention on capital returns at the start of the year, with investors now looking past day-to-day cigarette volumes to the bigger question: how much cash BAT can keep sending back while it pushes harder into vaping and nicotine pouches. Investegate BAT’s buyback programme, first
8 January 2026
······
Altria stock drops on ex-dividend move as Juul patent fight returns to view

Altria stock drops on ex-dividend move as Juul patent fight returns to view

NEW YORK, December 28, 2025, 23:38 ET — Market closed Altria Group shares ended Friday down 2.34% at $57.60, underperforming a flat-to-lower U.S. market as the stock traded ex-dividend, Investing.com data showed. Investing.com The move matters now because Altria is held largely for income, and dividend-related trading can distort the tape into year-end, when liquidity is thinner and positioning shifts quickly. It also matters because Altria’s payout is large enough to account for much of a one-day swing. The company’s $1.06 quarterly dividend implies an annual yield of about 7.4% at Friday’s close, keeping the stock in focus for yield
29 December 2025
·······
British American Tobacco Stock (BATS.L, BTI): £1.3bn Buyback, 2026 Outlook, and What Analysts Forecast as of Dec. 21, 2025

British American Tobacco Stock (BATS.L, BTI): £1.3bn Buyback, 2026 Outlook, and What Analysts Forecast as of Dec. 21, 2025

Dec. 21, 2025 — British American Tobacco p.l.c. (BAT) heads into year-end with a familiar investor tug-of-war: the market loves the company’s cash returns (dividends + buybacks), but keeps side-eyeing the regulatory and competitive turbulence in “smokeless” products—especially in the United States. With markets closed on Sunday, the latest reference point is Friday’s close (Dec. 19, 2025). BAT’s London-listed shares (LSE: BATS) ended the session at £42.36 (4,236p), down 1.14% on the day, even as the FTSE 100 rose. Trading volume was notably elevated versus the recent average—often a sign that investors are actively repositioning rather than simply drifting. MarketWatch+1
21 December 2025
······
British American Tobacco (BATS.L, BTI) Stock: £1.3bn Buyback Meets Cautious 2026 Outlook as Vuse Fights Illicit Vapes

British American Tobacco (BATS.L, BTI) Stock: £1.3bn Buyback Meets Cautious 2026 Outlook as Vuse Fights Illicit Vapes

LONDON (20 December 2025) — British American Tobacco p.l.c. stock has spent the final stretch of 2025 doing what tobacco stocks do best: defying expectations, paying investors, and attracting arguments. On one side of the ring, BAT is leaning hard into shareholder returns and balance-sheet repair — including a £1.3 billion share buyback for 2026 and continued daily repurchases under its current programme. Bat+2Securities and Exchange Commission+2On the other side: management is telling investors to expect 2026 growth at the lower end of its medium‑term targets, with the biggest pressure point still the U.S. vapour market, where illicit competition has
20 December 2025
······
British American Tobacco (BATS.L / BTI) Stock in Focus on 19 December 2025: Buyback Activity, Dividend Dates, Analyst Forecasts, and the 2026 Outlook

British American Tobacco (BATS.L / BTI) Stock in Focus on 19 December 2025: Buyback Activity, Dividend Dates, Analyst Forecasts, and the 2026 Outlook

London / New York — 19 December 2025 British American Tobacco p.l.c. (BAT) stock is ending the week with a familiar (and very shareholder-friendly) drumbeat: steady buybacks, a clearly telegraphed dividend schedule, and a fresh round of debate over what “lower end of guidance” really means for 2026. On 19 December 2025, BAT disclosed another “Transaction in Own Shares” notice, confirming it repurchased shares the prior day as part of its ongoing buyback programme first announced in March 2024. London South East That might sound routine—because it is—but routine matters in a stock that many investors own for cash returns
19 December 2025
·····
British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco p.l.c. (BAT) entered mid-December with its share price near multi-year highs, and the news flow on Wednesday, December 17, 2025 is very “capital allocation meets governance”: the company disclosed another daily share repurchase under its ongoing buyback programme and filed a director declaration under UK listing rules. Meanwhile, investors are still digesting BAT’s early-December FY2025 pre-close trading update, where management reaffirmed its medium-term growth algorithm but signaled that 2026 performance is likely to land at the lower end of its target range—largely because the U.S. vaping market remains distorted by illicit competition and uneven enforcement. Reuters+4Investing.com+4Moneyweb+4 Below
17 December 2025
······
British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

December 15, 2025 British American Tobacco p.l.c. stock is back in focus for income investors and “defensive” equity watchers—because the story is doing that very tobacco-company thing where cash returns look comforting while regulatory and category disruption refuse to be ignored. As of Monday, Dec. 15, 2025, British American Tobacco (LSE: BATS) traded around 4,268p (£42.68), up on the day, after a volatile stretch driven by BAT’s full-year pre-close update, a fresh £1.3 billion buyback plan for FY2026, and renewed debate over U.S. vaping competition and illicit products. London South East Below is a complete, publication-ready roundup of today’s (15.12.2025)
15 December 2025
·····
British American Tobacco Stock (BATS.L, BTI): 2026 Guidance, £1.3bn Buyback, Dividend Dates and Analyst Forecasts (Dec 13, 2025)

British American Tobacco Stock (BATS.L, BTI): 2026 Guidance, £1.3bn Buyback, Dividend Dates and Analyst Forecasts (Dec 13, 2025)

British American Tobacco p.l.c. (BAT) stock heads into the weekend in focus after a busy week of company updates, broker notes, and fresh debate about the regulation that shapes the global nicotine market. As of the last close (Friday, December 12, 2025), BAT shares on the London Stock Exchange (BATS.L) finished at 4,238p. Yahoo Finance In the U.S., BAT’s American Depositary Receipt (BTI) last closed at $57.10. MacroTrends The headline driver is BAT’s FY25 pre-close trading update (published December 9), where the company said it remains on track for full-year delivery, but expects 2026 performance to land at the lower
13 December 2025
······
British American Tobacco (BATS.L / BTI) Stock News Today: £1.3bn 2026 Buyback, U.S. Vape Headwinds, Dividends and Analyst Targets (12 December 2025)

British American Tobacco (BATS.L / BTI) Stock News Today: £1.3bn 2026 Buyback, U.S. Vape Headwinds, Dividends and Analyst Targets (12 December 2025)

British American Tobacco p.l.c. is in focus on 12 December 2025 after a busy week of updates: continued daily buybacks, a fresh £1.3bn extension for 2026, a pre-close trading update that kept FY2025 guidance intact but flagged FY2026 at the lower end of targets, plus an India divestment tied to debt reduction. Here’s the latest news, forecasts, and market analysis. Published: 12 December 2025 British American Tobacco p.l.c. (BAT) — ticker BATS in London (FTSE 100) and BTI as a U.S. ADR — is ending the week with investors weighing two competing narratives: bigger shareholder returns via an extended buyback,
12 December 2025
······
1 2

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop